ASTROGLIF®

TEMOZOLOMIDE
ASTROGLIF®

Available Presentations:

  • CAPSULES, 5 mg, 20 mg, 100 mg, 130mg, 140 mg, 180 mg, 250 mg
INN:temozolomide
Presentation: Capsules
5 mg, 20 mg, 100 mg, 130 mg, 140 mg, 180 mg, 250 mg.
ATC Group: L01AX03
Antitumor agent, alkylating compound
Scope of Application:The newly discovered multiform glioblastoma, malignant glioma, common metastatic melanoma
Status of Administration: prescription only
VED Status: listed in VED List
Marketing Authorization: LP-003152
Shelf Life: 2 years
Conditions of Storage: store at or below 25°C

THE INFORMATION ON THIS PAGE IS NOT AN ADVERTISEMENT AND IS INTENDED TO INFORM ON THE PRODUCTS MANUFACTURED BY THE COMPANY.

THE MEDICINAL PRODUCTS HAVE CONTRAINDICATIONS, CONTACT YOUR DOCTOR.